ARCH Venture Partners X, LLC Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
3
Insider Buys Sum
$52.3M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of ARCH Venture Partners X, LLC

Biography of ARCH Venture Partners X, LLC

No biography is available at this moment.

2025-10-27PurchaseNeumora Therapeutics, Inc. Common Stock
NMRA
10 percent owner
1.92M
1.3366%
$2.61$5M-31.23%
2025-08-01PurchasePrime Medicine, Inc.
PRME
10 percent owner
3.03M
1.988%
$3.30$10M-9.03%
2024-02-15PurchasePrime Medicine, Inc.
PRME
10 percent owner
3.2M
4.6348%
$6.25$20M-43.72%
2023-09-19PurchaseNeumora Therapeutics, Inc. Common Stock
NMRA
10 percent owner
1.5M
1.5879%
$17.00$25.5M-1.04%
2022-10-24PurchasePrime Medicine, Inc.
PRME
director
400,000
1.5758%
$17.00$6.8M-3.68%
Total: 5
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.